SALES ALERT: Unlock 10-40% Off on All Cell Products!

ACCELERATING DRUG DISCOVERY THROUGH DISEASE-RELEVANT
CELL MODELS

Advance scientific discoveries with our comprehensive suite of preclinical services, including iPSC solutions, Genome Editing, In Vitro Assays, and more. Explore our extensive range of human and animal primary cells, iPSCs, and customizable models for disease research.

Cell PRODUCTS

Discover our extensive collection of Human and Animal Cells, Clinical and Patient-Derived models. Trusted by researchers and scientists worldwide, our cells are consistently cited in research publications, attesting their quality and dependability.

PRECLINICAL CRO SERVICES

We offer iPSC reprogramming, Cas9 genome editing, directed differentiation, custom cell isolation, in vitro assays, and ASO screening services. Our team of PhD scientists provides disease-relevant, patent-derived models that accelerate drug discovery and disease understanding.

We specialize in complex assay development and execution for research support. Our expertise includes multi-cellular model building, 3D liver model signaling studies, and compound screening for iPSC-derived neurons and human immune cells.

DISCOVER
OUR CRO SERVICES

What Your Peers say about us

News & ARTICLES

Stay updated with the latest scientific discoveries, innovations, and breakthroughs: company news, industry insights, and events.

Global Genes RARE Advocacy Summit

Connect. Inspire. Learn Every year, Global Genes organizes one of the world’s largest gatherings for

10-40% Off Sitewide Promotion – All Cell Products

Fully Characterized, ready to use, and at your fingertips. For a limited time, iXCells Biotechnologies
iXCells-Biotechnologies- New-Facility

iXCells Biotechnologies Expands Operations; New Website Goes Live

IXCELLS BIOTECHNOLOGIES EXPANDS OPERATIONS; NEW WEBSITE GOES LIVE Increased operational capacity positions company for continued

IXCELLS BIOTECHNOLOGIES & TEBUBIO ESTABLISH PARTNERSHIP TO EXPAND PRODUCT DISTRIBUTION ACROSS EUROPE AND UK

iXCells Biotechnologies has entered into an agreement with Tebubio to enhance distribution of the company's

World’s leading annual all-immunology event

We’re thrilled to announce that iXCells will be exhibiting at the upcoming Immunology 2023 conference

Working on ADME-Tox models?

Replicate hepaftic unction and enhance the efficiency of drug metabolism, toxicology, and pharmacology studies.

iXCells Biotechnologies Expands CRISPR-Cas9 Cell Products and Genome Engineering Services

Gene Editing Services Deliver Disease Relevant Cell Models to Improve Preclinical Drug Development May 16,

Join iXCells Biotechnologies in Washington, DC, for the world’s leading annual all-immunology event

We’re thrilled to announce that iXCells will be exhibiting at the upcoming Immunology 2023 conference

Unlock a world of benefits!

Subscribe now and be among the first to enjoy exclusive product offers, indulge in premium content, and be the first to witness exciting new product launches.

    Unlock a world of benefits!

    Subscribe now and be among the first to enjoy exclusive product offers, indulge in premium content, and be the first to witness exciting new product launches.